20-62952880-A-G
Variant summary
Our verdict is Benign. Variant got -8 ACMG points: 0P and 8B. BP4_StrongBS2
The NM_022082.4(SLC17A9):āc.50A>Gā(p.Gln17Arg) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000207 in 964,538 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_022082.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -8 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
SLC17A9 | NM_022082.4 | c.50A>G | p.Gln17Arg | missense_variant | 1/13 | ENST00000370351.9 | NP_071365.4 | |
SLC17A9 | NM_001302643.2 | c.-31A>G | 5_prime_UTR_variant | 1/14 | NP_001289572.2 | |||
SLC17A9 | XR_936601.4 | n.172A>G | non_coding_transcript_exon_variant | 1/10 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
SLC17A9 | ENST00000370351.9 | c.50A>G | p.Gln17Arg | missense_variant | 1/13 | 1 | NM_022082.4 | ENSP00000359376 | P1 | |
SLC17A9 | ENST00000370349.7 | c.-31A>G | 5_prime_UTR_variant | 1/14 | 1 | ENSP00000359374 | ||||
SLC17A9 | ENST00000488738.5 | n.170A>G | non_coding_transcript_exon_variant | 1/11 | 2 |
Frequencies
GnomAD3 genomes AF: 0.000133 AC: 7AN: 52576Hom.: 0 Cov.: 0
GnomAD3 exomes AF: 0.0000295 AC: 3AN: 101790Hom.: 0 AF XY: 0.0000362 AC XY: 2AN XY: 55242
GnomAD4 exome AF: 0.0000132 AC: 12AN: 911934Hom.: 0 Cov.: 35 AF XY: 0.0000157 AC XY: 7AN XY: 446634
GnomAD4 genome AF: 0.000152 AC: 8AN: 52604Hom.: 0 Cov.: 0 AF XY: 0.000122 AC XY: 3AN XY: 24608
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jul 22, 2022 | The c.50A>G (p.Q17R) alteration is located in exon 1 (coding exon 1) of the SLC17A9 gene. This alteration results from a A to G substitution at nucleotide position 50, causing the glutamine (Q) at amino acid position 17 to be replaced by an arginine (R). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at